ASD | VSD | Fallot | AVSD | Complex | |
---|---|---|---|---|---|
Number of patients | 50 | 22 | 19 | 22 | 13 |
Pregnancies (n) | 126 | 63 | 44 | 48 | 28 |
Pregnancies/woman | 2.5 (1.4) | 2.9 (2.0) | 2.3 (1.5) | 2.3 (1.4) | 2.0 (1.8) |
Women with surgery | |||||
Pregnancies before surgery/woman | 0.6 (1.4)2-150 | 0.2 (0.5) | 0.5 (1.1) | 0.1 (0.3) | 0.1 (0.6) |
Pregnancies after surgery/woman | 1.6 (1.2) | 2.6 (2.2) | 1.6 (0.9) | 2.1 (1.5) | 1.8 (1.7) |
Abortion rate (%) | 16 | 10 | 16 | 17 | 36 |
Caesarean section rate (%) | 15 | 15 | 29 | 30 | 70† |
Pregnancy duration (months) | 8.8 (0.8) | 9.0 (0.2) | 9.0 (0.4) | 8.9 (0.5) | 8.2 (1.8) |
Pre-eclampsia/embolisation (n) | 2/1 | 1/1 | 0/0 | 1/0 | 0/0 |
Reduced wellbeing (%) | 10 | 10 | 24 | 5 | 22 |
NYHA class I–II at last follow up (%) | 100 | 100 | 95 | 100 | 85‡ |
Values are means (SD) unless otherwise stated.
↵2-150 p = 0.05, ASD v VSD/AVSD and complex; †p =0.005, complex v ASD, VSD, Fallot, AVSD;‡p = 0.005, complex v ASD.
ASD, atrial septal defect; AVSD, atrioventricular septal defect; Complex, complex shunt lesions; Fallot, tetralogy of Fallot; NYHA, New York Heart Association; reduced wellbeing, worse wellbeing at the time of last follow up than before pregnancy; VSD, ventricular septal defect.